HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goswami, M. Search for Related Content PubMed PubMed Citation Articles by Goswami, M.

The influence of clinical symptoms on quality of life in patients with narcolepsy

From the Narcolepsy Institute, Montefiore Medical Center, Bronx, NY.

Address correspondence and reprint requests to Dr. Meeta Goswami, Narcolepsy Institute, Montefiore Medical Center, 111 East 210 Street, Bronx, NY 10467-2490.

Abstract.

Quality of life is a multidimensional construct involving subjective well-being, health, and welfare. For the patient with narcolepsy, as for any patient with a chronic illness, clinical symptoms have a major impact on physical and psychosocial function and hence on quality of life. This article briefly reviews selected effects of narcolepsy and describes the results of studies undertaken by researchers at the Sleep-Wake Disorders Center of Montefiore Medical Center in New York City. The goal of these studies was to determine the social characteristics and perceived needs of patients and to document the prevalence of the clinical features of narcolepsy and their impact on quality of life. Using a combination of methodologies-mail survey, record review, and personal interviews-the researchers found that clinical symptoms of narcolepsy have a profound impact on the physical, mental, and social health of those affected with the disorder.

This article has been cited by other articles:

				D. M. Swope Rapid treatment of "wearing off" in Parkinson's disease Neurology, March 23, 2004; 62(6_suppl_4): S27 - S31. [Abstract] [Full Text]

				M. Guttman, D. Stewart, D. Hussey, A. Wilson, S. Houle, and S. Kish Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD Neurology, June 12, 2001; 56(11): 1559 - 1564. [Abstract] [Full Text] [PDF]

				P. T. Mannisto and S. Kaakkola Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors Pharmacol. Rev., December 1, 1999; 51(4): 593 - 628. [Abstract] [Full Text] [PDF]